QuidelOrtho Corp. (QDEL) has announced the pricing for a secondary offering managed by the underwriter. The offering is being conducted by Carlyle Partners VI Cayman Holdings, L.P. and involves approximately 8.26 million shares of the company's common stock.
All proceeds from this offering will go to the selling stockholder, as QuidelOrtho Corp. itself is not partaking in the sale of shares. Therefore, the company will not benefit financially from this transaction.
Goldman Sachs & Co. LLC is serving as the exclusive underwriter for the offering.
Completion of the offering, aimed for November 21, 2024, is contingent upon meeting standard closing conditions.
